SK bioscience has developed a new vaccine which can line up with AztraZeneca and Pfizer. They developed the vaccine together with the Institute for Protein Design (IPD) in University of Washington School of Medicine.  It was funded by Bill & Melinda Gates Foundation (BMGF) and Coalition for Epidemic Preparedness Innovation (CEPI) with support from European’s Horizon 2020 Program. It has been supported for almost $214 million by BMGF and CEPI.